Earnings Standouts: 52 Stocks Outperforming Wall Street Estimates
Research by the Bank for International Settlements said that equity markets tend to already price in earnings expectations well before official results are announced.
Harmony Biosciences Holdings Inc. (HRMY)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Walleye Capital Will England | 44,372 | $1,615,585 | 0.01% | |
| 2. | Polaris Capital Management Bernard Horn | 36,100 | $1,314,401 | 0.12% | |
| 3. | Quantedge Capital Pte Ltd Leow Kah Shin And Chua Choong Tze | 24,000 | $873,840 | -53% | 0.66% |
| 4. | Bayforest Capital Theodoros Tsagaris | 5,297 | $192,864 | -10% | 0.18% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $24.00 | 339,476 | $8,147,424.00 | 10,651,120 | 2020-08-21 | Filing | |
| $34.30 | 3,922 | $134,524.60 | 42,702 | 2020-08-26 | Filing | |
| $34.20 | 823 | $28,146.60 | 38,780 | 2020-08-25 | Filing | |
| $24.00 | 132,503 | $3,180,072.00 | 4,409,803 | 2020-08-21 | Filing | |
| $34.30 | 3,057 | $104,855.10 | 37,957 | 2020-08-24 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $37.15 | 3,746 | $139,171.39 | 24,521 | 2026-01-26 | Filing | |
| $35.92 | 20,961 | $752,833.18 | 0 | 2026-01-15 | Filing | |
| $40.11 | 5,933 | $237,956.61 | 0 | 2025-12-12 | Filing | |
| $40.11 | 20,000 | $802,146.00 | 0 | 2025-12-12 | Filing | |
| $39.54 | 20,000 | $790,896.00 | 0 | 2025-12-05 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 285,500 | $10,395,055 | 1.56% | |
| 2. | 278,845 | $10,152,747 | 0% | |
| 3. | 272,926 | $9,937,232 | 0% | |
| 4. | 265,242 | $9,657,462 | 0% | |
| 5. | 264,638 | $9,635,469 | 0.01% |
News See All
Is Harmony Biosciences Holdings, Inc. (HRMY) A Good Stock To Buy Now?
Is HRMY a good stock to buy? We came across a bullish thesis on Harmony Biosciences Holdings, Inc. on r/StockPickNews by EaseQuiet529. In this article, we will summarize the bulls’ thesis on HRMY.
10 Best Stocks to Buy Right Now According to AI
The US economy is navigating a complex and difficult environment defined by decelerating growth, persistent inflationary shocks, and a shifting consumer landscape.
Harmony Biosciences Holdings (HRMY) Announces Financial Results for Q1 2026
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) is one of the best healthcare stocks to buy for the long term. Harmony Biosciences Holdings, Inc.
10 Best Healthcare Stocks to Buy for the Long Term
On May 7, Haig Bathgate, CEO of Callanish Capital, appeared on CNCB to talk about his bullish view on the global markets amid the Iran war, and how its impact would be short-lived, especially when compared...
10 Best Small-Cap Value Stocks to Buy
Small-cap stocks are the real thing in an equity market under immense pressure amid geopolitical and monetary policy uncertainties.
Deutsche Bank Cuts PT on Harmony Biosciences Holdings (HRMY) to $30 From $31
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) is one of the best cheap biotech stocks to buy now. On February 25, Deutsche Bank adjusted the price target on Harmony Biosciences Holdings, Inc.
12 Cheap Biotech Stocks to Buy Now
On February 27, Eli Casdin, Casdin Capital CEO, appeared on CNBC’s ‘Closing Bell’ to talk about the biotech sector.
Truist Securities Downgrades Harmony Biosciences Holdings, Inc. (HRMY) to Hold After Patent Trial Developments
TheFly reported on February 20 that Truist Securities downgraded HRMY from Buy to Hold following the conclusion of its bench trial against Paragraph IV filer AET Pharma. The analyst pointed out that...
20 Best Investments in 2026
The S&P 500 reached a new high as investors focused on upcoming tech sector earnings, and U.S. markets reportedly recovered in the last week of January amid heightened geopolitical concerns.
Hedge Fund Resource Center